SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Florida enthusiastically welcomes Calcalist conference to Miami

Bitsight acquires Cybersixgill in $115 million deal to strengthen cyber risk management

Full list of Israeli startup M&As in 2024

Immunai and Teva launch multi-tear AI collaboration for smarter drug development

Buzz

Most popular

Daily

Weekly

1

Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"

2

Is your solitaire opponent actually a bot?

3

Cloudera acquires Israeli startup Octopai to advance metadata and AI integration

4

Former Snyk founder Guy Podjarny secures $125M for AI-powered software startup Tessl

5

CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments

PolyPid

2 stories about PolyPid

Dikla Czackes Akselbrad PolyPid 20

“In the biotech industry, the one thing that is missing more than anything else is funding"

Dikla Czackes Akselbrad, executive vice president and CFO of PolyPid, joins Michael Matias to discuss her bio-pharmaceutical company

Drug Conduction Company Prepares for Nasdaq IPO

08.10.17|Golan Hazani

Clinical stage PolyPid develops technology for the predetermined, controlled and localized release of drugs at a targeted site